When

Friday, December 11, 2015

6:00 AM - 7:45 AM

WheRE

Las Vegas, NV

Islander A/F
Mandalay Bay Hotel & Casino
Las Vegas, Nevada

faculty

Richard L. Rauck, MD, FIPP (Interactive Professor)
Clinical Associate Professor
Department of Anesthesiology
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Timothy R. Deer, MD
President and Chief Executive Officer
Center for Pain Relief
Charleston, West Virginia

Eric J. Grigsby, MD, MBA
CEO and President, Neurovations
Founder and Medical Director
Napa Pain Institute
Napa, California


This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from Jazz Pharmaceutials.

This program is not affiliated with NANS.

Target Audience

The educational design of this activity addresses the needs of interventional pain specialists and other allied healthcare professionals involved in the treatment of patients with severe chronic pain.

Statement of Need/Program Overview

An estimated 100 million adults in the United States suffer from at least 1 chronically painful condition.1 Complexities in the underlying pathophysiologic mechanisms and clinical manifestations result in a large number of patients for whom conventional management strategies fail to produce adequate pain relief or the desired functional gains.2 For some of these individuals, intrathecal delivery of analgesic medications can be a safe and effective treatment modality.3, 4 The US Food and Drug Administration has approved 2 analgesics—ziconotide and morphine—as intrathecal medications for patients with severe chronic pain.5 Despite the availability of these agents, however, the use of intrathecal therapy for chronic pain is often suboptimal, in part owing to poor patient selection, systemic barriers, and safety concerns (eg, opioid-induced respiratory depression).6 Using an engaging educational format, this Interactive Exchange™ program will provide attendees with the latest published evidence and practical guidance on evaluating candidates for intrathecal drug delivery, the potential benefits and risks of various intrathecal analgesics, and the essential elements of initial and ongoing patient monitoring plans.

References

  1. Institute of Medicine (2011). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.

  2. Gatchel, R. J., Y. B. Peng, M. L. Peters, P. N. Fuchs and D. C. Turk (2007). "The biopsychosocial approach to chronic pain: scientific advances and future directions." Psychol Bull 133(4): 581-624.

  3. Onofrio, B. M., T. L. Yaksh and P. G. Arnold (1981). "Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin." Mayo Clin Proc 56(8): 516-520.

  4. Prager, J., T. Deer, R. Levy, B. Bruel, E. Buchser, D. Caraway, M. Cousins, M. Jacobs, G. McGlothlen, R. Rauck, P. Staats and L. Stearns (2014). "Best practices for intrathecal drug delivery for pain." Neuromodulation 17(4): 354-372; discussion 372.

  5. Ver Donck, A., J. H. Vranken, M. Puylaert, S. Hayek, N. Mekhail, J. Van Zundert (2014). “Intrathecal drug administration in chronic pain syndromes.” Pain Pract 14(5): 461-476.

  6. Coffey, R. J., M. L. Owens, S. K. Broste, M. Y. Dubois, F. M. Ferrante, D. M. Schultz, L. J. Stearns and M. S. Turner (2009). "Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain." Anesthesiology 111(4): 881-891.

Educational Objectives

After completing this activity, the participant should be better able to:

  1. Assess candidates for intrathecal therapy via comprehensive medical histories, physical examinations, accurate pain diagnoses, and psychological evaluations

  2. Describe the clinical profiles, dosing strategies, and other prescribing considerations for analgesic medications approved for intrathecal delivery

  3. Construct intrathecal regimens for chronic pain that reflect potential medication benefits and risks, guideline recommendations, previous treatment responses, and therapeutic trial results

  4. Tailor intrathecal drug therapy based on ongoing monitoring of analgesia, functional outcomes, and treatment-emergent adverse events

Program Agenda

6:00 AM – 6:15 AM: Registration and Breakfast

6:15 AM – 6:20 AM: Faculty Introductions

6:20 AM – 6:30 AM: Scientific Updates on Intrathecal Analgesics

6:30 AM – 7:20 AM: Best Practices for Intrathecal Therapy in Patients with Chronic Pain 

7:20 AM – 7:30 AM: Choose-A-Case: Audience-Directed Learning

7:30 AM –7:45 AM: Ask the Experts: Question and Answer Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity. For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americas With Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Sean O’Toole prior to the live event at sotoole@integritasgrp.com

Register Now

attend event